Do you need long-acting oral insulin Trelagliptin?

Trelagliptin (Trelagliptin) is a new, long-acting, highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor suitable for once-weekly administration. In the clinical setting, it is expected that this newly developed once-weekly DPP-4 inhibitor trolagliptin will initially be used as a switch to a daily DPP-4 inhibitor. Due to the specific molecular structure of trotagliptin, it is metabolized very slowly in the body, mainly in the kidneys. After taking the drug for 7 days, the cumulative urinary excretion rate was about 76%, but the inhibition rate of DPP-4 activity was still 77.4%. Tretagliptin is usually used in conjunction with an appropriate diet and exercise regimen. Doctors generally do not recommend treatment with this medication if you have a history of allergy to trotagliptin or its ingredients.